Namilumab (MT203)

Namilumab is a biologic being tested for psoriasis.

Mechanism Primary

anti-inflammatory

Phase

Indication

Psoriasis

Manufacturer

Takeda

Manufacturer URL

Link To Past Trial Page

Mechanism Secondary

granulocyte macrophage colony stimulating factor antagonist

Drug Type